Shire

This study is checking how safe the drug Replagal is for people with Fabry disease in India. About 5 children and adults who have not taken Replagal before will get the drug every 2 weeks for a year. The main goal is to track any side effects or reactions.

This study is a long-term registry that collects health information from people with Gaucher disease, regardless of their treatment. It does not test any new drug or procedure. The goal is to better understand the disease and track the safety and effectiveness of treatments over …